• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Professional Development Training

Description: Provide professional development opportunities for technical review staff

A. FY 2010 Professional Development Training

Briefing Status: COMPLETED

Prior Briefing Status: ON TRACK

Milestone DescriptionMilestone DateMilestone StatusMilestone Completion Date

1. Hold quarterly RPM Seminars - FY 10 Q1

12/31/2009

Completed 10/29/2010

2. Hold quarterly RPM Seminars - FY 10 Q2

3/31/2010

Completed 1/20/2010

3. Hold quarterly RPM Seminars - FY 10 Q3

6/30/2010

Completed 4/22/2010

4. Hold quarterly RPM Seminars - FY 10 Q4

9/30/2010

Completed 7/21/2010

5. Hold annual Pharmacology/Toxicology Reviewers Retreat

9/30/2010

Completed 9/2/2010

6. Hold annual Clinical Reviewers Retreat

12/31/2010

12/31/2012

Completed 10/12/2012

B. FY 2012 Professional Development Training

Briefing Status: COMPLETED

Milestone DescriptionMilestone DateMilestone StatusMilestone Completion Date

1. Hold annual Pharmacology/Toxicology Reviewers Retreat

9/30/2012

Completed 9/24/2012

2. Hold quarterly RPM Seminars – FY12 Q1

1/26/2012

Completed 1/26/2012

3. Hold quarterly RPM Seminars – FY12 Q2

5/12/2012

Completed 5/9/2012

4. Clinical Review Education Program (CREP) Pediatric Psychiatry Update

5/15/2012

Completed 5/15/2012

5. Clinical Review Education Program (CREP) Obesity Update

6/28/2012

Completed 6/28/2012

Key Projects Legend

Milestone StatusDefinition
Not Yet StartedWork for specific milestone has not yet been started.
CompletedMilestone and/or overall project is completed.
On TrackMilestone - On track for completion by milestone deadline. Quarter status - Project is on track for completion based on overall milestone status.
On HoldMilestone - On hold, but deadline for completion has not passed. Quarter status - Project is on hold, based on overall milestone status.
DelayedMilestone - Delayed as it has not been completed and deadline has passed. Quarter status - Project is delayed based on overall milestone status.

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.